Thursday, May 29, 2014
Publication and contact
small molecule probe to image tumor response to chemotherapy in vivo
Cell culture and mouse
studies have identified an apoptosis-sensing molecular probe that could be
used to image tumor response to treatment in vivo. A biocompatible,
caspase-sensitive fluorescent probe that self-assembles within cells after
caspase cleavage and thiol-mediated cyclization was identified. In cultured
tumor cell lines, staurosporine- or doxorubicin-induced
apoptosis led to a dose- and time-dependent increase in probe fluorescence
within cells compared with no treatment. In a mouse xenograft model of
cervical cancer, i.v. infusion of the probe plus doxorubicin led to greater
fluorescence within tumor cells than either infusion of the probe plus saline
or doxorubicin alone. Next steps include adapting the probe for PET or MRI
Staurosporine is a research reagent that acts as a pan-kinase inhibitor.
Doxorubicin is a generic chemotherapy drug.
Published online May 29, 2014
Patented; available for
Ye, D. et al. Nat. Chem.;
published online April 28, 2014;
Contact: Jianghong Rao, Stanford University, Stanford,
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]